| Primary |
| Type 2 Diabetes Mellitus |
31.4% |
| Diabetes Mellitus Non-insulin-dependent |
18.8% |
| Type 1 Diabetes Mellitus |
17.4% |
| Diabetes Mellitus Insulin-dependent |
11.6% |
| Drug Use For Unknown Indication |
11.5% |
| Diabetes Mellitus |
5.8% |
| Weight Decreased |
0.7% |
| Glucose Tolerance Impaired |
0.4% |
| Product Used For Unknown Indication |
0.4% |
| Weight Control |
0.4% |
| Insulin Resistance |
0.3% |
| Neuralgia |
0.3% |
| Blood Cholesterol Increased |
0.2% |
| Insulin Resistant Diabetes |
0.2% |
| Catheterisation Cardiac |
0.1% |
| Hypertension |
0.1% |
| Thyroid Disorder |
0.1% |
| Arthropathy |
0.0% |
| Blood Pressure Abnormal |
0.0% |
| Blood Triglycerides Increased |
0.0% |
|
| Nausea |
20.0% |
| Weight Decreased |
15.6% |
| Blood Glucose Increased |
14.8% |
| Injection Site Pain |
11.2% |
| Weight Increased |
5.7% |
| Vomiting |
5.4% |
| Drug Ineffective |
4.1% |
| Medication Error |
3.0% |
| Wrong Drug Administered |
2.6% |
| Tremor |
2.5% |
| Injection Site Bruising |
1.8% |
| Hypoglycaemia |
1.7% |
| Incorrect Dose Administered |
1.7% |
| Drug Effect Decreased |
1.6% |
| Blood Glucose Decreased |
1.5% |
| Urticaria |
1.5% |
| Injection Site Irritation |
1.4% |
| Vision Blurred |
1.4% |
| Treatment Noncompliance |
1.4% |
| Diarrhoea |
1.2% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
45.5% |
| Type 1 Diabetes Mellitus |
21.3% |
| Diabetes Mellitus |
12.0% |
| Drug Use For Unknown Indication |
5.9% |
| Diabetes Mellitus Non-insulin-dependent |
5.2% |
| Insulin Resistance |
2.7% |
| Hypertension |
1.4% |
| Diabetes Mellitus Insulin-dependent |
0.9% |
| Gastrointestinal Disorder |
0.9% |
| Infection Prophylaxis |
0.9% |
| Blood Cholesterol Increased |
0.7% |
| Blood Glucose |
0.5% |
| Cardiac Disorder |
0.5% |
| Osteoporosis |
0.5% |
| Arthritis |
0.2% |
| Blood Cholesterol Decreased |
0.2% |
| Cardiac Pacemaker Insertion |
0.2% |
| Diabetic Foot Infection |
0.2% |
| Fluid Retention |
0.2% |
| Gout |
0.2% |
|
| Nausea |
24.2% |
| Blood Glucose Increased |
14.6% |
| Weight Increased |
13.4% |
| Weight Decreased |
5.7% |
| Injection Site Pain |
5.1% |
| Vomiting |
5.1% |
| Drug Prescribing Error |
4.5% |
| Urticaria |
3.8% |
| Drug Effect Decreased |
3.2% |
| Injection Site Haematoma |
3.2% |
| Hypoglycaemia |
2.5% |
| Increased Appetite |
1.9% |
| Rash Pruritic |
1.9% |
| Stomach Discomfort |
1.9% |
| Vision Blurred |
1.9% |
| Wheezing |
1.9% |
| Anaphylactoid Reaction |
1.3% |
| Dizziness |
1.3% |
| Drug Ineffective |
1.3% |
| Glycosylated Haemoglobin Increased |
1.3% |
|
| Concomitant |
| Type 2 Diabetes Mellitus |
27.4% |
| Diabetes Mellitus |
20.2% |
| Product Used For Unknown Indication |
11.8% |
| Drug Use For Unknown Indication |
4.7% |
| Hypertension |
4.0% |
| Blood Pressure |
3.4% |
| Pain |
3.3% |
| Cardiac Disorder |
3.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.7% |
| Back Pain |
2.4% |
| Type 1 Diabetes Mellitus |
2.3% |
| Weight Loss Diet |
2.0% |
| Blood Cholesterol |
1.7% |
| Depression |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hypersensitivity |
1.6% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.6% |
| Renal Disorder |
1.6% |
| Sleep Disorder |
1.6% |
| Osteopenia |
1.4% |
|
| Weight Decreased |
27.0% |
| Weight Increased |
13.2% |
| Blood Glucose Increased |
8.6% |
| Loss Of Consciousness |
5.9% |
| Nausea |
5.9% |
| Urticaria |
3.9% |
| Drug Ineffective |
3.3% |
| Vision Blurred |
3.3% |
| Wrong Technique In Drug Usage Process |
3.3% |
| Flushing |
2.6% |
| Hyperlipidaemia |
2.6% |
| Myocardial Infarction |
2.6% |
| Throat Irritation |
2.6% |
| Tremor |
2.6% |
| Vomiting |
2.6% |
| Diabetes Mellitus |
2.0% |
| Dyspnoea |
2.0% |
| Gastrointestinal Haemorrhage |
2.0% |
| Hospitalisation |
2.0% |
| Nervousness |
2.0% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
42.9% |
| Blood Cholesterol Increased |
28.6% |
| Thyroid Disorder |
14.3% |
| Gastric Disorder |
10.7% |
| Neuralgia |
1.8% |
| Type 1 Diabetes Mellitus |
1.8% |
|
| Gastric Disorder |
88.9% |
| Weight Increased |
11.1% |
|
